130 related articles for article (PubMed ID: 35803850)
1. "Location of cutaneous malignant melanoma in Sweden 2004-2018 - mortality and sex differences".
Önefäldt D; Zommorodi S; Falk Delgado A
J Plast Reconstr Aesthet Surg; 2022 Sep; 75(9):3398-3405. PubMed ID: 35803850
[TBL] [Abstract][Full Text] [Related]
2. Reduced disease-specific survival following a diagnosis of multiple primary cutaneous malignant melanomas-a nationwide, population-based study.
Utjés D; Lyth J; Lapins J; Eriksson H
Int J Cancer; 2017 Dec; 141(11):2243-2252. PubMed ID: 28799271
[TBL] [Abstract][Full Text] [Related]
3. The proportion cured of patients diagnosed with Stage III-IV cutaneous malignant melanoma in Sweden 1990-2007: A population-based study.
Eriksson H; Lyth J; Andersson TM
Int J Cancer; 2016 Jun; 138(12):2829-36. PubMed ID: 26815934
[TBL] [Abstract][Full Text] [Related]
4. Cutaneous malignant melanoma in south Sweden 1965, 1975, and 1985. A histopathologic review.
Måsbäck A; Westerdahl J; Ingvar C; Olsson H; Jonsson N
Cancer; 1994 Mar; 73(6):1625-30. PubMed ID: 8156490
[TBL] [Abstract][Full Text] [Related]
5. Trends in cutaneous malignant melanoma in Sweden 1997-2011: thinner tumours and improved survival among men.
Lyth J; Eriksson H; Hansson J; Ingvar C; Jansson M; Lapins J; Månsson-Brahme E; Naredi P; Stierner U; Ullenhag G; Carstensen J; Lindholm C
Br J Dermatol; 2015 Mar; 172(3):700-6. PubMed ID: 25323770
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors in localized invasive primary cutaneous malignant melanoma: results of a large population-based study.
Eriksson H; Frohm-Nilsson M; Järås J; Kanter-Lewensohn L; Kjellman P; Månsson-Brahme E; Vassilaki I; Hansson J
Br J Dermatol; 2015 Jan; 172(1):175-86. PubMed ID: 24910143
[TBL] [Abstract][Full Text] [Related]
7. Epidemiological characteristics of cutaneous malignant melanoma of the head and neck--a population-based study.
Gillgren P; Månsson-Brahme E; Frisell J; Johansson H; Larsson O; Ringborg U
Acta Oncol; 1999; 38(8):1069-74. PubMed ID: 10665765
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology of malignant melanoma in central Europe: risk factors and prognostic predictors. Results of the Central Malignant Melanoma Registry of the German Dermatological Society.
Garbe C; Orfanos CE
Pigment Cell Res; 1992; Suppl 2():285-94. PubMed ID: 1409431
[TBL] [Abstract][Full Text] [Related]
9. Is head and neck melanoma a distinct entity? A clinical registry-based comparative study in 5702 patients with melanoma.
Hoersch B; Leiter U; Garbe C
Br J Dermatol; 2006 Oct; 155(4):771-7. PubMed ID: 16965427
[TBL] [Abstract][Full Text] [Related]
10. Body site of cutaneous malignant melanoma--a study on patients with hereditary and multiple sporadic tumours.
Gillgren P; Brattström G; Frisell J; Palmgren J; Ringborg U; Hansson J
Melanoma Res; 2003 Jun; 13(3):279-86. PubMed ID: 12777983
[TBL] [Abstract][Full Text] [Related]
11. Association of Mohs Micrographic Surgery vs Wide Local Excision With Overall Survival Outcomes for Patients With Melanoma of the Trunk and Extremities.
Demer AM; Hanson JL; Maher IA; Liszewski W
JAMA Dermatol; 2021 Jan; 157(1):84-89. PubMed ID: 33084853
[TBL] [Abstract][Full Text] [Related]
12. Do sex and site matter? Different age distribution in melanoma of the trunk among Swedish men and women.
Pérez-Gómez B; Aragonés N; Gustavsson P; Lope V; López-Abente G; Pollán M
Br J Dermatol; 2008 Apr; 158(4):766-72. PubMed ID: 18241261
[TBL] [Abstract][Full Text] [Related]
13. A prospective population-based study of cutaneous malignant melanoma of the head and neck.
Gillgren P; Månsson-Brahme E; Frisell J; Johansson H; Larsson O; Ringborg U
Laryngoscope; 2000 Sep; 110(9):1498-504. PubMed ID: 10983950
[TBL] [Abstract][Full Text] [Related]
14. Malignant melanoma incidence in Connecticut (United States): time trends and age-period-cohort modeling by anatomic site.
Chen YT; Zheng T; Holford TR; Berwick M; Dubrow R
Cancer Causes Control; 1994 Jul; 5(4):341-50. PubMed ID: 8080946
[TBL] [Abstract][Full Text] [Related]
15. Sex Differences in Cutaneous Melanoma: Incidence, Clinicopathological Profile, Survival, and Costs.
Buja A; Rugge M; Damiani G; Zorzi M; De Toni C; Vecchiato A; Del Fiore P; Spina R; Baldo V; Brazzale AR; Rossi CR; Mocellin S
J Womens Health (Larchmt); 2022 Jul; 31(7):1012-1019. PubMed ID: 35076310
[No Abstract] [Full Text] [Related]
16. Incidence and anatomic presentation of cutaneous malignant melanoma in central Canada during a 50-year period: 1956 to 2005.
Pruthi DK; Guilfoyle R; Nugent Z; Wiseman MC; Demers AA
J Am Acad Dermatol; 2009 Jul; 61(1):44-50. PubMed ID: 19395122
[TBL] [Abstract][Full Text] [Related]
17. Cutaneous malignant melanoma of the head and neck. Analysis of treatment results and prognostic factors in 581 patients: a report from the Swedish Melanoma Study Group.
Ringborg U; Afzelius LE; Lagerlöf B; Adami HO; Augustsson I; Blomqvist E; Boeryd B; Carlin E; Edström S; Eldh J
Cancer; 1993 Feb; 71(3):751-8. PubMed ID: 8431856
[TBL] [Abstract][Full Text] [Related]
18. Comparison of anatomical locations of cutaneous melanoma in men and women: a population-based study in France.
Chevalier V; Barbe C; Le Clainche A; Arnoult G; Bernard P; Hibon E; Grange F
Br J Dermatol; 2014 Sep; 171(3):595-601. PubMed ID: 24725117
[TBL] [Abstract][Full Text] [Related]
19. Effect of primary site on prognosis in patients with cutaneous malignant melanoma. A study using a new model to analyse anatomical locations.
Gillgren P; Brattström G; Frisell J; Persson JO; Ringborg U; Hansson J
Melanoma Res; 2005 Apr; 15(2):125-32. PubMed ID: 15846146
[TBL] [Abstract][Full Text] [Related]
20. Prognostic risk factors of first recurrence in patients with primary stages I-II cutaneous malignant melanoma - from the population-based Swedish melanoma register.
Lyth J; Falk M; Maroti M; Eriksson H; Ingvar C
J Eur Acad Dermatol Venereol; 2017 Sep; 31(9):1468-1474. PubMed ID: 28419674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
